Navigation Links
Johnson & Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs
Date:6/4/2009

Early stage compounds and new filings targeted in five therapeutic areas

Expanding indications for strong core products builds "pipeline in a product"

Leveraging global capabilities and reach drives growth efforts in emerging markets

Biomarkers and diagnostics combine with therapies to advance personalized medicine

Company's vision focuses on improving human health and reducing global burden of disease

NEW BRUNSWICK, N.J., June 4 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) will be reviewing the growth strategies and pipeline for its Pharmaceutical business at a meeting with the investment community today. Senior leaders from the company's pharmaceutical segment will outline how continued expansion of its core products, progress in its pipeline, and an end-to-end approach to its research and development (R&D) will fuel its long-term growth and address unmet medical needs.

The company will highlight its plans for addressing these needs in five therapeutic areas:

  • Neuroscience -- Johnson & Johnson is a leader in neuroscience, which not only includes central nervous system (CNS) disorders, but also treatment of pain -- both acute and chronic. The company will continue to focus on its traditional areas of strength and high unmet need -- schizophrenia, epilepsy, bipolar disorder and pain -- while taking a different approach to neuroscience drug development, including greater emphasis in the future on cognition and dementia.

  • Cardiovascular disease and Metabolism -- In this area, the company is focused on three major conditions -- cardiovascular disease, diabetes, and obesity -- where incidence rates are soaring, placing a trem
    '/>"/>

SOURCE Johnson & Johnson
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Johnson & Johnson Files Arbitration Demand Against Schering-Plough to Resolve Dispute Over Agreements for REMICADE(R) and SIMPONI(TM)
2. Boston Scientific Announces Two Directors Leave Board as Burns Named CEO of Xerox and Johnson Confirmed as Under Secretary of Energy
3. Champions Shawn Johnson & Phil Jackson Wear Energy Muse Jewelry
4. Johnson & Johnson to Participate in Deutsche Bank 34th Annual Health Care Conference
5. Johnson & Johnson to Host Analyst Conference Call To Review Six-Month Trial Results From NEVO RES I
6. EF Johnson Technologies, Inc. Announces First Quarter 2009 Financial Results
7. Johnson & Johnson to Participate in Bank of America and Merrill Lynch 2009 Health Care Conference
8. Weill Cornell and Cornells Johnson School present first annual business and medicine symposium
9. Johnson & Johnson to Webcast Annual Meeting of Shareholders
10. Johnson & Johnson Reports 2009 First-Quarter Results:
11. Trust for Americas Health Supports Recommendations from Robert Wood Johnson Foundation Commission to Build a Healthier America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)NEW YORK, Dec. 4 Thousands of KPMG LLP employees came together in more than 90 offices nationwide today, to participate in a community service event which combines the audit, tax and advisory firm,s
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
(Date:12/4/2009)Rockville, MD "Why is it that men can be bastards and women must wear pearls and smile?" wrote author Lynn Hecht Schafran. The answer, according to an article in the Journal of Vision , may lie in
(Date:12/4/2009)BOSTON, Dec. 4 Substantial progress has been made over the last 15 years in the healthcare community,s ability to diagnose and treat epilepsy and its complications. Yet this progress in epilepsy man
Breaking Medicine News(10 mins):Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Are angry women more like men? 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 3Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 4
... may spur discoveries, but some warn privacy needs...hDay News) -- Increasing patient control of health...earch is conducted, say Children,s Hospital Boston...rsonally controlled health records (PCHRs) will gi...
...enza viruses persist in low levels year-round in t...w crop of the virus emerge afresh in tropical zone...perate regions around the globe" Researchers have ... and accurately determine which strains to include...
...ril 16 Aflac Incorporated,(NYSE: AFL ) announced...l,results after the market closes on April 23, 200...0041202/CLTH019LOGO ), In conjunction with the e...ncorporated Chairman and CEO Dan Amos,will discuss...
... risk of losing memory and thinking skills, study ...ews) -- Men are one and a half times more likely t...w research shows. , "These findings are in contras...," study author Rosebud Roberts, of the Mayo Clini...
...r outlines how hospitals can use NuVia(TM) technol...tinually updated and expanding informati..., April 16 GHX has introduced NuVia(TM), an,artif...enefits of the new approach as compared to more tr...
...cellence Issue Brief, WASHINGTON, April 16 The C...s issued its fifth issue brief on retirement plans... Plans. The brief, which,was written by Alicia H. ...ocal pension plans, overall, are as well funded as...
Other Medicine News:Health News:Patient-Controlled Health Records Could Change Future of Research 2Health News:Aflac Incorporated To Release First Quarter Results on April 23, 2008 2Health News:GHX Introduces NuVia(TM), an Artificial Intelligence-based Technology That Enables a New Approach to Content Management for Healthcare Providers 2Health News:GHX Introduces NuVia(TM), an Artificial Intelligence-based Technology That Enables a New Approach to Content Management for Healthcare Providers 3Health News:The Miracle of Funding by State and Local Pension Plans 2
(Date:12/3/2009)NEW YORK, Dec. 3 Guidepoint Global, LLC , a leading primary research firm, today announced the launch of their Sleep Apnea Tracker, a monthly longitudinal data release that monitors and projects tre
(Date:12/3/2009)SUNNYVALE, Calif., Dec. 3 Pharmacyclics, Inc. (Nasdaq: PCYC ), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of immune media
(Date:12/3/2009)WILMINGTON, Del., Dec. 3 ParagonRx, a Delaware-based company specializing in pharmaceutical risk management and optimal medication use, will host a free webinar on Wednesday, Dec. 9, on the FDA,s dra
Breaking Medicine Technology:Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2Stephen H Feinstein Ph D of Kansas Elected NAMI National Board President 54238 1Hard To Treat Diseases 28HTDS 29 exclusive agent and partner of NCPC 54234 1Hard To Treat Diseases 28HTDS 29 exclusive agent and partner of NCPC 54234 2Hard To Treat Diseases 28HTDS 29 exclusive agent and partner of NCPC 54234 3Spike Footballs this Fall Without Straining the Spine 54231 1Spike Footballs this Fall Without Straining the Spine 54231 2
DK Meyerhoefer Chalazion Curette
Phaco Emulsifier AAP 2000
Horizon Phacoemulsification Unit
Photon Laser Phacoemulsification System
Medicine Products: